No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
A bilayer small diameter in vitro
vascular model for evaluation of drug induced vascular injury
W. D. Kerns, E. Arena, and D. G. Morgan, Am. J. Pathol. 135, 339 (1989).
I. Mikaelian, M. Cameron, D. A. Dalmas, B. E. Enerson, R. J. Gonzalez, S. Guionaud, P. K. Hoffmann, N. M. King, M. P. Lawton, M. S. Scicchitano, H. W. Smith, R. A. Thomas, J. L. Weaver, and T. S. Zabka, Toxicol. Pathol. 42, 635 (2014).
C. Louden, D. Brott, A. Katein, T. Kelly, S. Gould, H. Jones, G. Betton, J. P. Valetin, and R. J. Richardson, Toxicol. Pathol. 34, 19 (2006).
W. Kerns, L. Schwartz, K. Blanchard, S. Burchiel, D. Essayan, E. Fung, R. Johnson, M. Lawton, C. Louden, J. MacGregor, F. Miller, P. Nagarkatti, D. Robertson, P. Snyder, H. Thomas, B. Wagner, A. Ward, and J. Zhang, Toxicol. Appl. Pharmacol. 203, 62 (2005).
J. M. Gonzalez, A. M. Briones, B. Somoza, C. J. Daly, E. Vila, B. Starcher, J. C. McGrath, M. C. Gonzalez, and S. M. Arribas, Am. J. Physiol. Heart Circ. Physiol. 291, H804 (2006).
R. T. Megens, S. Reitsma, P. H. Schiffers, R. H. Hilgers, J. G. De Mey, D. W. Slaaf, M. G. oude Egbrink, and M. A. van Zandvoort, J. Vasc. Res. 44, 87 (2007).
T. A. Swanson, T. Conte, B. Deeley, S. Portugal, J. M. Kreeger, L. A. Obert, E. C. Joseph, T. A. Wisialowski, S. A. Sokolowski, C. Rief, P. Nugent, M. P. Lawton, and B. E. Enerson, Toxicol. Pathol. 42, 784–791 (2014).
D. Brott, S. Gould, H. Jones, J. Schofield, H. Prior, J. P. Valentin, S. Bjurstrom, K. Kenne, I. Schuppe-Koistinen, A. Katein, L. Foster-Brown, G. Betton, R. Richardson, G. Evans, and C. Louden, Toxicol. Appl. Pharmacol. 207, 441 (2005).
Article metrics loading...
In pre-clinical safety studies, drug-induced vascular injury (DIVI) is defined as an adverse response to a drug characterized by degenerative and hyperplastic changes of endothelial cells and vascular smooth muscle
cells. Inflammation may also be seen, along with extravasation of red blood cells into the smooth muscle layer (i.e., hemorrhage). Drugs that cause DIVI are often discontinued from development after considerable cost has occurred. An in vitro vascular model has been developed using endothelial and smooth muscle
cells in co-culture across a porous membrane mimicking the internal elastic lamina. Arterial flow rates of perfusion media within the endothelial chamber of the model induce physiologic endothelial cell alignment. Pilot testing with a drug known to cause DIVI induced extravasation of red blood cells into the smooth muscle layer in all devices with no extravasation seen in control devices. This engineered vascular model offers the potential to evaluate candidate drugs for DIVI early in the discovery process. The physiologic flow within the co-culture model also makes it candidate for a wide variety of vascular biology investigations.
Full text loading...
Most read this month